Kim Juwon, Lee Sung Ho, Kim Hye Ree, Chung Tae-Wan, Choi Ji-Hoon, Kim Ju Youn, Park Kyoung-Min, On Young Keun, Kim June Soo, Park Seung-Jung
Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea.
J Clin Med. 2022 Apr 11;11(8):2133. doi: 10.3390/jcm11082133.
The snare technique can be used to overcome unsuitable cardiac venous anatomies for left ventricular (LV) lead implantation in cardiac resynchronization therapy (CRT) procedures. However, limited data exist regarding performance of the snare technique. We classified 262 patients undergoing CRT procedure into the snare ( = 20) or conventional group ( = 242) according to the LV lead implantation method. We compared the safety, efficacy, and composite outcome (all-cause death and heart failure readmission) at 3 years post-implant between the snare and conventional groups. In the snare group, all LV leads were implanted safely using orthodromic ( = 15) or antidromic ( = 5) techniques, and no immediate complications occurred including vessel perforation, tamponade, and lead dislodgement. During follow-up, LV lead threshold and impedance remained stable without requiring lead revision in the snare group. There were no significant between-group differences regarding LV ejection fraction increase (12 ± 13% vs. 12 ± 13%, = 0.929) and LV end-systolic volume reduction (18 ± 48% vs. 28 ± 31%, = 0.501). Both groups exhibited comparable CRT-response rates (62.5% vs. 60.6%, = 1.000). The risk of primary outcome was not significantly different between the two groups (25.9% vs. 30.9%, = 0.817). In patients who failed conventional LV lead implantation for CRT, the snare technique could be a safe and effective solution to overcome difficult coronary venous anatomy.
在心脏再同步治疗(CRT)手术中,圈套技术可用于克服左心室(LV)导线植入时心脏静脉解剖结构不合适的问题。然而,关于圈套技术性能的数据有限。我们根据LV导线植入方法将262例接受CRT手术的患者分为圈套组(n = 20)或传统组(n = 242)。我们比较了圈套组和传统组植入后3年的安全性、有效性和复合结局(全因死亡和心力衰竭再入院)。在圈套组中,所有LV导线均使用顺行(n = 15)或逆行(n = 5)技术安全植入,未发生包括血管穿孔、心包填塞和导线移位在内的即刻并发症。在随访期间,圈套组的LV导线阈值和阻抗保持稳定,无需进行导线修正。两组在LV射血分数增加(12±13% vs. 12±13%,P = 0.929)和LV收缩末期容积减少(18±48% vs. 28±31%,P = 0.501)方面无显著组间差异。两组的CRT反应率相当(62.5% vs. 60.6%,P = 1.000)。两组的主要结局风险无显著差异(25.9% vs. 30.9%,P = 0.817)。对于因CRT而常规LV导线植入失败的患者,圈套技术可能是克服困难冠状静脉解剖结构的一种安全有效的解决方案。